Oxygen Therapy Equipment Market is Expanding USD 10.2 Billion by 2035 | Fact.MR Report

Fact.MR today released its latest report on the Oxygen Therapy Equipment Market, providing comprehensive insights into the global market's tremendous growth driven by the rising prevalence of respiratory diseases, increasing demand for home healthcare, and advancements in portable oxygen technologies.

For More Insights into the Market, Request a Sample of this Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=7678

Valued at USD 4.2 billion in 2025, the market is projected to grow at a compound annual growth rate (CAGR) of 8.9%, reaching USD 10.2 billion by 2035. This expansion highlights the critical role of oxygen therapy equipment in managing chronic respiratory conditions and enhancing patient quality of life.

Market Outlook and Growth Projections:

The oxygen therapy equipment market is poised for significant growth from 2025 to 2035, fueled by the increasing burden of respiratory disorders like chronic obstructive pulmonary disease (COPD), asthma, and pneumonia, alongside the growing adoption of home-based care. Oxygen therapy equipment, including oxygen concentrators, cylinders, and delivery devices, provides essential supplemental oxygen to patients with low blood oxygen levels.

The report projects the market to grow from USD 4.2 billion in 2025 to USD 10.2 billion by 2035, with a CAGR of 8.9%. This growth is driven by technological advancements, an aging population, and expanding healthcare infrastructure, creating substantial opportunities for manufacturers and healthcare providers.

Key Drivers Fueling Market Demand:

The primary drivers of the market include the rising prevalence of respiratory diseases, with COPD affecting over 384 million people globally and causing 3.2 million deaths annually, according to the World Health Organization. The aging population, projected to reach 2.1 billion by 2050, increases demand for oxygen therapy to manage age-related respiratory conditions. The report highlights the growing popularity of portable oxygen concentrators, which accounted for 63.1% of the market share in 2022, driven by innovations in lightweight, battery-powered devices that enhance patient mobility.

The shift toward home healthcare, supported by policies like U.S. Medicare's expanded coverage for home oxygen therapy in 2020, is a significant growth factor. Additionally, advancements in telemedicine and IoT-integrated devices for real-time monitoring are boosting market adoption.

Browse Full Report: https://www.factmr.com/report/oxygen-therapy-equipment-market

Challenges and Restraints in the Sector:

Despite its promising outlook, the market faces challenges. High costs of advanced oxygen therapy equipment, such as portable concentrators costing USD 2,000-5,000, and ongoing maintenance expenses limit accessibility, particularly in low-income regions. The report notes stringent regulatory standards, such as FDA requirements in the U.S. and CE marking in Europe, which can delay product approvals and increase compliance costs.

Side effects like skin irritation and the lack of reimbursement policies in some regions further restrain market growth. Providers must address these challenges by developing cost-effective solutions, enhancing regulatory compliance, and improving reimbursement frameworks to ensure broader adoption.

Segment-Wise Insights and Dominant Trends:

The report provides detailed segmentation analysis, identifying oxygen source equipment, such as concentrators and cylinders, as the dominant product segment, holding a 62.44% share in 2023 due to their critical role in initiating therapy. Oxygen delivery devices, including nasal cannulas and masks, are projected to grow at a CAGR of 9.0%, driven by diverse patient needs. By portability, portable devices dominate with a 63.1% share, fueled by innovations like the Drive DeVilbiss 1060AW 10-liter concentrator launched in 2023.

COPD leads applications with a 34.6% share, reflecting its high prevalence. Hospitals dominate as end users, but home care is the fastest-growing segment, with a CAGR of 6.4%, driven by user-friendly devices. Key trends include the rise of smart oxygen concentrators with IoT integration, energy-efficient designs, and sustainable materials, enhancing patient outcomes and environmental impact.

Regional Outlook and Growth Hotspots:

North America holds the largest market share, with a 35.21% revenue share in 2023, driven by advanced healthcare infrastructure, high COPD prevalence (16 million diagnosed in the U.S.), and supportive reimbursement policies. Europe follows, with Germany and the UK leading due to robust healthcare systems and adoption of high-flow nasal cannula (HFNC) therapy.

The Asia-Pacific region is expected to exhibit the fastest growth, with a projected CAGR of 10%, fueled by rising healthcare investments, increasing respiratory disease prevalence, and growing medical tourism in China, India, and Japan. Latin America and the Middle East and Africa (MEA) are emerging markets, supported by improving healthcare access. The report identifies Asia-Pacific as a key growth engine due to its large population and expanding healthcare infrastructure.

Recent Developments:

The market has seen significant advancements in 2024 and early 2025. In May 2023, Drive DeVilbiss Healthcare launched the 1060AW, a 10-liter oxygen concentrator designed for rural and semi-urban settings, enhancing reliability and energy efficiency. In February 2023, React Health acquired Invacare's respiratory product line, including the Platinum 10L Concentrator and HomeFill systems, strengthening its market position.

Posts on X highlight innovations like AI-supported oxygen therapy devices and sustainability-focused concentrators, reflecting market trends toward smart, eco-friendly solutions. Additionally, the FDA's approval of 15 new portable oxygen concentrators between 2020 and 2024 has expanded options for mobile therapy, driving market growth.

Key Players Insights:

Leading players are driving innovation through product launches and strategic acquisitions. Philips Healthcare leads with its Respironics EverGo portable concentrator, while Linde Healthcare excels in liquid oxygen systems for home care. Invacare Corporation, Inogen, Inc., and Fisher & Paykel Healthcare focus on portable and energy-efficient devices, with Inogen launching advanced concentrators in 2023. Other key players, including Chart Industries, ResMed, HERSILL S.L., Teleflex Incorporated, and Rhythm Healthcare, are investing in IoT-integrated and sustainable solutions. Recent moves include Philips' 2024 expansion of oxygen therapy solutions in Asia-Pacific. These companies are pursuing R&D, acquisitions, and regional expansion to meet growing demand, with strong growth projected through 2035.

Competitive Landscape:

The market features a competitive ecosystem with key players driving innovation and market share. Companies profiled include Philips Healthcare, Linde Healthcare, Invacare Corporation, Inogen, Inc., Fisher & Paykel Healthcare, Chart Industries, ResMed, HERSILL S.L., Teleflex Incorporated, and Rhythm Healthcare. These firms lead in developing advanced, patient-centric oxygen therapy solutions. The report includes a detailed competition dashboard, benchmarking, and market share analysis, highlighting strategies such as product innovation, mergers, and expansion into emerging markets. As the market evolves, these players are well-positioned to capitalize on opportunities in portable and home-based oxygen therapy.

Strategic Recommendations and Future Implications:

Fact.MR's report offers actionable recommendations, urging stakeholders to invest in portable, IoT-integrated oxygen concentrators and sustainable designs to meet patient and environmental needs. Providers should focus on affordable solutions for emerging markets and enhance reimbursement frameworks to improve accessibility. The study includes value chain analysis, PESTLE factors, and SWOT assessments to support strategic decision-making. As respiratory disease prevalence and home healthcare demand rise, oxygen therapy equipment will remain critical for improving patient outcomes and healthcare efficiency globally.

Fact.MR delivers comprehensive market reports and valuable business insights, uncovering trends, growth paths, and competitive landscapes. Committed to accuracy and reliability, Fact.MR empowers businesses with critical data and strategic recommendations, enhancing market positioning. With a global presence and experienced analysts.

Check out More Related Studies Published by Fact.MR:

Cannabinoied Therapy Market https://www.factmr.com/connectus/sample?flag=S&rep_id=7678

Magnetic Therapy Devices Market https://www.factmr.com/report/3412/magnetic-therapy-devices-market

Image Guided Radiotherapy Market https://www.factmr.com/report/4001/image-guided-radiotherapy-market

Cardiac Resynchronization Therapy Market https://www.factmr.com/report/cardiac-resynchronization-therapy-market

CAR T-Cell Therapy Market https://www.factmr.com/report/car-t-cell-therapy-market

Gene Therapy for SCID Market https://www.factmr.com/report/gene-therapy-for-scid-market

Contact:

US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232
Email: sales@factmr.com

About Fact.MR

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.

This release was published on openPR.